OMEROS CORP
Develops first-in-class therapeutics for challenging diseases with unmet medical needs.
OMER | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6821431029
- LEI:
- Country:
- United States of America
- Address:
- 201 ELLIOTT AVENUE WEST, 98119 SEATTLE
- Website:
- https://www.omeros.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Omeros Corporation is a biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company builds and advances a diverse pipeline of first-in-class drug candidates designed to address challenging diseases and disorders with significant unmet medical needs. Emphasizing innovative science, Omeros develops therapeutics with novel mechanisms of action that target previously untapped receptors and enzymes, avoiding the development of "me-too" products. Its approach combines novel discovery with strategic translational research and clinical programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all OMEROS CORP filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OMEROS CORP
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OMEROS CORP via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
